Phase 4 Study of the Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel

Trial Profile

Phase 4 Study of the Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Celecoxib (Primary) ; Aspirin; Clopidogrel
  • Indications Acute coronary syndromes; Ankylosing spondylitis; Back pain; Bladder cancer; Dysmenorrhoea; Embolism and thrombosis; Gouty arthritis; Juvenile rheumatoid arthritis; Myocardial infarction; Non-small cell lung cancer; Osteoarthritis; Pain; Peripheral arterial disorders; Postoperative pain; Prostate cancer; Rheumatic disorders; Rheumatoid arthritis; Stroke
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Apr 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top